<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Micro-<z:chebi fb="40" ids="33697">RNAs</z:chebi> (miRNAs) are a class of non-coding <z:chebi fb="40" ids="33697">RNAs</z:chebi> that post-transcriptionally regulate gene expression via the <z:chebi fb="40" ids="33697">RNA</z:chebi> interference pathway </plain></SENT>
<SENT sid="1" pm="."><plain>In addition to roles in <z:mpath ids='MPATH_458'>normal</z:mpath> development, miRNAs have recently been implicated in a range of human diseases, including <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>We recently demonstrated that a polycistronic cluster of miRNAs, miR-17-92, is oncogenic in a mouse model for Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>This is due, in part, to a reduced apoptotic program </plain></SENT>
<SENT sid="4" pm="."><plain>In an effort to understand the regulation of miR-17-92, we have studied the promoter structure of this miRNA cluster </plain></SENT>
<SENT sid="5" pm="."><plain>The primary transcript initiates from a consensus initiator sequence downstream of a nonconsensus TATA box </plain></SENT>
<SENT sid="6" pm="."><plain>The core promoter region contains two functional E2F transcription factor binding sites </plain></SENT>
<SENT sid="7" pm="."><plain>Chromatin immunoprecipitation demonstrates that E2F3 is the primary E2F family member that occupies the promoter </plain></SENT>
<SENT sid="8" pm="."><plain>These data place miR-17-92 in a regulatory loop between E2F3 and the miR-17 target E2F1 </plain></SENT>
<SENT sid="9" pm="."><plain>We propose a model whereby miR-17-92 promotes cell proliferation by shifting the E2F transcriptional balance away from the pro-apoptotic E2F1 and toward the proliferative E2F3 transcriptional network </plain></SENT>
</text></document>